ATLANTA, GA – – (Businesswire – October 31, 2019) – – Holzer & Holzer, LLC is investigating whether certain statements made by Merit Medical Systems, Inc. (“Merit” or the “Company”) (NASDAQ: MMSI) complied with federal securities laws. On October 30, 2019, the Company announced its third quarter results in which it lowered revenue guidance for the rest of the fiscal year and eliminated previously issued guidance for 2020. The price of Merit’s stock fell following the announcement. If you purchased shares of Merit and suffered a loss on that investment, you are encouraged to contact Marshall P. Dees, Esq. at email@example.com or Luke R. Kennedy at firstname.lastname@example.org, or by toll-free telephone at (888) 508-6832 to discuss your legal rights.